Literature DB >> 10212118

Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.

A Vasudevan1, Y Qian, A Vogt, M A Blaskovich, J Ohkanda, S M Sebti, A D Hamilton.   

Abstract

The design, synthesis, and biological evaluation of a family of peptidomimetic inhibitors of protein geranylgeranyltransferase-I (PGGTase-I) are reported. The inhibitors are based on the C-terminal CAAL sequence of many geranylgeranylated proteins. Using 2-aryl-4-aminobenzoic acid derivatives as mimetics for the central dipeptide (AA), we have attached a series of imidazole and pyridine derivatives to the N-terminus as cysteine replacements. These non-thiol-containing peptidomimetics show exceptional selectivity for PGGTase-I over the closely related enzyme protein farnesyltransferase (PFTase). This selectivity is retained in whole cells where the inhibitors were shown to block the geranylgeranylation of Rap-1A without affecting the farnesylation of small GTP-binding proteins such as Ras.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212118     DOI: 10.1021/jm9900873

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

1.  Synthesis and evaluation of 3- and 7-substituted geranylgeranyl pyrophosphate analogs.

Authors:  Michelle Maynor; Sarah A Scott; Emily L Rickert; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2008-02-12       Impact factor: 2.823

2.  Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.

Authors:  William A Freed-Pastor; Hideaki Mizuno; Xi Zhao; Anita Langerød; Sung-Hwan Moon; Ruth Rodriguez-Barrueco; Anthony Barsotti; Agustin Chicas; Wencheng Li; Alla Polotskaia; Mina J Bissell; Timothy F Osborne; Bin Tian; Scott W Lowe; Jose M Silva; Anne-Lise Børresen-Dale; Arnold J Levine; Jill Bargonetti; Carol Prives
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.

Authors:  Anne-Kathrin Hechinger; Kristina Maas; Christoph Dürr; Franziska Leonhardt; Gabriele Prinz; Reinhard Marks; Ulrike Gerlach; Maike Hofmann; Paul Fisch; Jürgen Finke; Hanspeter Pircher; Robert Zeiser
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

4.  Prenylation differentially inhibits insulin-dependent immediate early gene mRNA expression.

Authors:  J Lee Franklin; Maggie O Amsler; Joseph L Messina
Journal:  Biochem Biophys Res Commun       Date:  2016-04-14       Impact factor: 3.575

5.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Protein geranylgeranyltransferase-I of Trypanosoma cruzi.

Authors:  Kohei Yokoyama; John R Gillespie; Wesley C Van Voorhis; Frederick S Buckner; Michael H Gelb
Journal:  Mol Biochem Parasitol       Date:  2007-10-02       Impact factor: 1.759

7.  Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression.

Authors:  Emily S Mathews; David J Mawdsley; Macie Walker; Jacob H Hines; Marina Pozzoli; Bruce Appel
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

8.  Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.

Authors:  K M Clapp; M L Ellsworth; R S Sprague; A H Stephenson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

9.  Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation.

Authors:  Yuri K Peterson; Xiang S Wang; Patrick J Casey; Alexander Tropsha
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

10.  Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds.

Authors:  Masaru Watanabe; Hannah D G Fiji; Lea Guo; Lai Chan; Sape S Kinderman; Dennis J Slamon; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.